Mikrobiologi.net/FKM

Mikrobiologi.net > FKM > Medlemmar > Christian G. Giske > C.V  
Christian G. Giske C.V.

Personliga data
Födelseort: Ålesund, Norge.
Gift, två barn.

Utbildning
9408-0006: Läkarlinjen, Norges Teknisk-Naturvitenskapelige Universitet (NTNU), Trondheim,  Norge.                                                                                                                      2003-2007: Doktorandutbildning Karolinska Institutet


Arbetskarriär
-0007-0107: Allmäntjänstgöring (AT) Nordland Sentralsjukhus, Bodö, Norge
-0107-0201: Allmäntjänstgöring (AT) Brönnöy Vårdcentral, Brönnöysund, Norge
-0201-0210: Marinofficer/skeppsläkare i Norska Marinen
-0210-0707: Specialiseringstjänstgöring (ST) Karolinska Universitetssjukhuset Solna, Avd för klinisk mikrobiologi                                                                                                           -0707-       : Specialistläkare Karolinska Universitetssjukhuset Solna, Klinisk mikrobiologi

Arbetskarriär
-0007-0107: Allmäntjänstgöring (AT) Nordland Sentralsjukhus, Bodö, Norge
-0107-0201: Allmäntjänstgöring (AT) Brönnöy Vårdcentral, Brönnöysund, Norge
-0201-0210: Marinofficer/skeppsläkare i Norska Marinen
-0210-0707: Specialiseringstjänstgöring (ST) Karolinska Universitetssjukhuset Solna, Avd för klinisk mikrobiologi                                                                                                           -0707-1001: Specialistläkare Karolinska Universitetssjukhuset Solna, Klinisk mikrobiologi      -1001: Biträdande överläkare Karolinska Universitetssjukhuset Solna, Klinisk mikrobiologi     

Arbetskarriär
-0007-0107: Allmäntjänstgöring (AT) Nordland Sentralsjukhus, Bodö, Norge
-0107-0201: Allmäntjänstgöring (AT) Brönnöy Vårdcentral, Brönnöysund, Norge
-0201-0210: Marinofficer/skeppsläkare i Norska Marinen
-0210-0707: Specialiseringstjänstgöring (ST) Karolinska Universitetssjukhuset Solna, Avd för klinisk mikrobiologi                                                                                                           -0707-1001: Specialistläkare Karolinska Universitetssjukhuset Solna, Klinisk mikrobiologi      -1001: Biträdande överläkare Karolinska Universitetssjukhuset Solna, Klinisk mikrobiologi     

Publikationer

A. Originalartiklar

1.      Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010 Jan 15;50(2):202-9.

 

2.      Hell E, Giske CG, Nelson A, Römling U, Marchini G. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol. [Epub ahead of print]

 

3.      Samuelsen Ø, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010 Jan;54(1):346-52.

 

4.      Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54.

 

5.      Hernes SS, Hagen E, Tofteland S, Finsen NT, Christensen A, Giske CG, Spindler C, Bakke PS, Bjorvatn B. Transthoracic fine-needle aspiration in aetiological diagnosis of community-acquired pneumonia. Clin Microbiol Infect. 2009 Jul 22. [Epub ahead of print]

 

6.      Schön T, Juréen P, Giske CG, Chryssanthou E, Sturegård E, Werngren J, Kahlmeter G, Hoffner SE, Angeby KA. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother. 2009 Oct;64(4):786-93.

 

7.      Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009 Aug;53(8):3365-70.

 

8.      Källman O, Giske CG, Samuelsen Ø, Wretlind B, Kalin M, Olsson-Liljequist B. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli. Microb Drug Resist. 2009 Jun;15(2):91-5.

 

9.      Nelson A, Hultenby K, Hell E, Riedel HM, Brismar H, Flock JI, Lundahl J, Giske CG, Marchini G. Staphylococcus epidermidis isolated from newborn infants express pilus-like structures and are inhibited by the cathelicidin-derived antimicrobial peptide LL37. Pediatr Res. 2009 Aug;66(2):174-8.

 

10.  Samuelsen Ø, Naseer U, Tofteland S, Skutlaberg DH, Onken A, Hjetland R, Sundsfjord A, Giske CG. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother. 2009 Apr;63(4):654-8.

 

11.  Källman O, Motakefi A, Wretlind B, Kalin M, Olsson-Liljequist B, Giske CG. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels. J Antimicrob Chemother. 2008 Nov;62(5):986-90.

 

12.  Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs. Scand J Infect Dis. 2008;40(6-7):487-94.

 

13.  Libisch B, Giske CG, Kovács B, Tóth TG, Füzi M. Identification of the first VIM metallo-beta-lactamase-producing multiresistant Aeromonas hydrophila strain. J Clin Microbiol. 2008 May;46(5):1878-80.

 

14.  Giske CG, Buarø L, Sundsfjord A, Wretlind B. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microb Drug Resist. 2008 Mar;14(1):23-30.

 

15.  Samuelsen Ø, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country. J Antimicrob Chemother. 2008 Apr;61(4):827-30.

 

16.  Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008 Mar;60(3):255-61.

 

17.  Giske CG, Libisch B, Colinon C, Scoulica E, Pagani L, Füzi M, Kronvall G, Rossolini GM. Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol. 2006 Dec;44(12):4309-15.

 

18.  Kais M, Spindler C, Kalin M, Ortqvist A, Giske CG. Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR. Diagn Microbiol Infect Dis. 2006 Jul;55(3):169-78.

 

19.  Giske CG, Borén C, Wretlind B, Kronvall G. Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA. Clin Microbiol Infect. 2005 Aug;11(8):662-9.

 

20.  El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS. 2005 Mar;113(3):187-96.

B. Övriga artiklar

  1. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Cantón R. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010 Feb;16(2):112-22.

  2. Petersson J, Kalin M, Giske CG. Quantitative lower respiratory tract cultures and how to interpret them. Infection must be discriminated from colonization]. Lakartidningen. 2009 Aug 19-25;106(34):2052-6.

  3. Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, Cantón R, Walsh TR. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother. 2009 Jan;63(1):1-4.

  4. Tegmark Wisell K, Kahlmeter G, Giske CG. Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue. J Antimicrob Chemother. 2008 Jul;62(1):35-40.

  5. Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008 Mar;52(3):813-21.
  6. Giske CG, Ge J, Nordmann P. Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa. J Antimicrob Chemother. 2009 Aug;64(2):430-1.

  7. Hanberger H, Odenholt I, Giske CG, Kahlmeter G. Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime. Lakartidningen. 2009 Jan 28-Feb 3;106(5):291-2.

  8. Samuelsen Ø, Buarø L, Toleman MA, Giske CG, Hermansen NO, Walsh TR, Sundsfjord A. The first metallo-beta-lactamase identified in Norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrob Agents Chemother. 2009 Jan;53(1):331-2.

  9. Eriksson M, Bennet R, Fuhrmann D, Giske CG, Rylander M. Invasive pneumococcal infection can cause meningitis in children. Uncertainty about the mass protective effect of the vaccine from USA. Lakartidningen. 2007 Jun 13-26;104(24-25):1906, 1908-10.

  10. Petersson J, Giske CG, Aufwerber E, Jörbeck H. Nosocomial infections with multiresistant bacteria--not only staphylococci. Lakartidningen. 2006 Aug 30-Sep 5;103(35):2478-81.

  11. Giske CG, Wretlind B. Quinolones should not be administered in monotherapy for Pseudomonas aeruginosa infection. Lakartidningen. 2006 Apr 5-11;103(14):1121-2.

  12. Giske CG, Rylander M, Kronvall G. VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden. Antimicrob Agents Chemother. 2003 Sep;47(9):3034-5.

    Övriga meriter

    -Svensk representant i EUCAST steering committee (European Committee on Antimicrobial Susceptibility Testing)

    -Medlem av Referensgruppen för antibiotikafrågor (RAF)  

    -Ordförande för RAFs metodgrupp (RAF-M)

    -Ledamot i styrgruppen för ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)

    -Chefsredaktör för Drug Resistance updates 

    Övriga meriter

    -Svensk representant i EUCAST steering committee (European Committee on Antimicrobial Susceptibility Testing)

    -Medlem av Referensgruppen för antibiotikafrågor (RAF)  

    -Ordförande för RAFs metodgrupp (RAF-M)

    -Ledamot i styrgruppen för ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)

    -Chefsredaktör för Drug Resistance updates 

Övriga meriter

-Svensk representant i EUCAST steering committee (European Committee on Antimicrobial Susceptibility Testing)

-Medlem av Referensgruppen för antibiotikafrågor (RAF)  

-Ordförande för RAFs metodgrupp (RAF-M)

-Ledamot i styrgruppen för ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)

-Chefsredaktör för Drug Resistance updates 



2024-06-21 08:45
Ⓒ Allt material på denna webbplats skyddas av upphovsrättslagen.
Upphovs- och förfoganderätten tillhör Mikrobiologi.net och respektive upphovsman